Data / Form D filings / Ventyx Biosciences, Inc.
Ventyx Biosciences, Inc.: Form D filings
Ventyx Biosciences, Inc., a company in San Diego, CA, filed 4 Form D notices with the SEC between 2021 and 2024. The latest, on September 30, 2024, reports $27 million sold of a $27 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 12790 EL CAMINO REAL, SUITE 200, San Diego, CA, 92130
- Phone
- (858) 945-2393
- Industry
- Other
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1851194
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | New notice | $26,999,940 | $26,999,940 | 1 | Sep 23, 2024 | sec.gov | |
| Sep 20, 2021 | New notice | $50,999,998 | $50,999,991 | $7 | 17 | Sep 9, 2021 | sec.gov |
| Jul 16, 2021 | Amendment | $114,299,988 | $114,299,988 | 24 | Feb 26, 2021 | sec.gov | |
| Mar 15, 2021 | New notice | $57,299,993 | $57,299,993 | 23 | Feb 26, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Sheila S. Gujrathi | Director | |
| Mark S. Forman | Executive Officer | |
| William S. White | Director | |
| Allison S. Hulme | Director | |
| Matthew Moore | Executive Officer | |
| Onaiza S. Cadoret-Manier | Director | |
| Somasundaram Subramaniam | Director | |
| Raju Mohan | Executive Officer, Director | |
| John Nuss | Executive Officer |
Other companies in California that filed recently
- MoFlo Acquisitions, Inc. $587.5 million · Nov 2, 2026
- BC Movie, LLC offering · Nov 2, 2026
- Jana Education San Jose LLC $200,000 · Nov 2, 2026
- Crosscut SPV Frontier LP - Series 2 $23.4 million · Oct 30, 2026
- Series 23-1, a series of StartEngine Private Funds LLC $314,025 · Oct 30, 2026
- Omnissa Holdco LLC offering · Oct 30, 2026
Every Form D from the week of Sep 30, 2024 · All recent filings in California · All recent Other filings
Read from SEC EDGAR. Amount sold is what Ventyx Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.